July 12, 2021

Flora Growth (FLGC) Grows the Cheapest Cannabis in the World

Midas Letter
Midas Letter
Flora Growth (FLGC) Grows the Cheapest Cannabis in the World
/

Flora Growth Corp (NASDAQ:FLGC) is a brand new cannabis company but has already achieved significant milestones over its three-year history. The latest and perhaps the most notable being its recent NASDAQ listing and US$16.67 million capital raise. Flora Growth is leveraging its Colombian EU-GMP certified organic, outdoor growing facility with one of the best cost-structures in the world. The company can produce each gram of dry flower for just six cents ($0.06).

“All outdoor organic cannabis cultivation practice that has allowed us to deliver one of the best cost-structures in the world at $0.06 per gram of dry flower. When you compare that to North American counterparts, we are talking a cost of gram of dry flower of $1.25 -$1.80. So clearly, this is a significant economic moat that will ensure that we are a global cannabis player for the long term” – Flora Growth CEO Luis Merchan

Flora Growth has also developed a robust portfolio of brands. The company has seventy different licences across twelve countries selling over three hundred products online and in brick-and-mortar stores. Across five operating divisions, Flora Growth sells flower, isolates and various consumer packaged goods (CPG), including skincare, clothing, food & beverage, dietary supplements and cosmetics.

Watch the full interview to understand Flora Growth’s expanding product portfolio, its upcoming revenue numbers, and its competitive advantages across the many different markets it operates in.

Related Articles

Disclosure

Midas Letter is provided as a source of information only, and is in no way to be construed as investment advice. James West, the author and publisher of the Midas Letter, is not authorized to provide investor advice, and provides this information only to readers who are interested in knowing what he is investing in and how he reaches such decisions.

Investing in emerging public companies involves a high degree of risk and investors in such companies could lose all their money. Always consult a duly accredited investment professional in your jurisdiction prior to making any investment decision.

Midas Letter occasionally accepts fees for advertising and sponsorship from public companies featured on this site. James West and/or Midas Letter may also receive compensation from companies affiliated with companies featured on this site. James West and/or Midas Letter also invests in companies on this site and so readers should view all information on this site as biased.